These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12232486)

  • 21. [Radiofrequency ablation of colorectal metastases to the liver: results since the first application in the Netherlands].
    Blussé van Oud-Alblas M; Fioole B; Jansen MC; van Duijnhoven FH; van Hillegersberg R; Rijken AM; van Coevorden F; Borel Rinkes IH
    Ned Tijdschr Geneeskd; 2008 Apr; 152(15):880-6. PubMed ID: 18512529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.
    Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC
    Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
    Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
    Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immediate and Long-term Results of Radiofrequency Ablation for Colorectal Liver Metastases.
    Cirimbei C; Rotaru V; Chitoran E; Pavaleanu O; Cirimbei SE
    Anticancer Res; 2017 Nov; 37(11):6489-6494. PubMed ID: 29061837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance.
    Pereira PL; Siemou P; Rempp HJ; Hoffmann R; Hoffmann RT; Kettenbach J; Clasen S; Helmberger T
    Eur Radiol; 2024 Jul; 34(7):4663-4671. PubMed ID: 38041717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiofrequency ablation: a minimally invasive technique with multiple applications.
    Bilchik AJ; Rose DM; Allegra DP; Bostick PJ; Hsueh E; Morton DL
    Cancer J Sci Am; 1999; 5(6):356-61. PubMed ID: 10606477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
    Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
    Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases.
    Eltawil KM; Boame N; Mimeault R; Shabana W; Balaa FK; Jonker DJ; Asmis TR; Martel G
    J Surg Oncol; 2014 Nov; 110(6):734-8. PubMed ID: 24965163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resection or radiofrequency ablation of colorectal liver metastasis.
    Jasarović D; Stojanović D; Mitrović N; Stevanović D
    Vojnosanit Pregl; 2014 Jun; 71(6):542-6. PubMed ID: 25039107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer.
    Kornprat P; Jarnagin WR; DeMatteo RP; Fong Y; Blumgart LH; D'Angelica M
    Arch Surg; 2007 Nov; 142(11):1087-92. PubMed ID: 18025338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early PET/CT after radiofrequency ablation in colorectal cancer liver metastases: is it useful?
    Liu ZY; Chang ZH; Lu ZM; Guo QY
    Chin Med J (Engl); 2010 Jul; 123(13):1690-4. PubMed ID: 20819630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical short-term results of radiofrequency ablation in patients with liver metastases from colorectal cancer.
    Basdanis G; Michalopoulos A; Papadopoulos V; Tzeveleki I; Efthimiadis Ch; Kosmidis Ch; Mekras D; Harlaftis N
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s187-9. PubMed ID: 15655617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-time ultrasonography-computed tomography fusion imaging for staging of hepatic metastatic involvement in patients with colorectal cancer: initial results from comparison to US seeing separate CT images and to multidetector-row CT alone.
    Stang A; Keles H; Hentschke S; Seydewitz C; Keuchel M; Pohland C; Dahlke J; Weilert H; Wessling J; Malzfeldt E
    Invest Radiol; 2010 Aug; 45(8):491-501. PubMed ID: 20458251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
    Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD
    Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients.
    Jakobs TF; Hoffmann RT; Trumm C; Reiser MF; Helmberger TK
    Anticancer Res; 2006; 26(1B):671-80. PubMed ID: 16739337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Radiofrequency ablation (RFA) in colorectal cancer with hepatic metastases].
    Takada J; Katsuki Y; Hamada H; Tsuji Y
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1673-5. PubMed ID: 16315905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thermal protection of targeted air instillation in CT-guided radiofrequency ablation].
    Kamusella P; Wiggermann P; Wissgott C; Andresen R; Stroszczynski C
    Rofo; 2011 Oct; 183(10):952-5. PubMed ID: 21748697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
    Dupré A; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2017 Oct; 43(10):1901-1907. PubMed ID: 28888801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort.
    Rouyer M; Smith D; Laurent C; Becouarn Y; Guimbaud R; Michel P; Tubiana-Mathieu N; Balestra A; Jové J; Robinson P; Noize P; Moore N; Ravaud A; Fourrier-Réglat A;
    Target Oncol; 2016 Feb; 11(1):83-92. PubMed ID: 26298481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.